GRK2 inhibitory polypeptide that specifically inhibits Gβγ activation of GRK2. Corresponds to the Gβγ-binding domain and acts as a cellular Gβγ antagonist.
GRK2i, also known as G protein-coupled receptor kinase 2 inhibitor, is a small-molecule compound designed to selectively inhibit the activity of GRK2, a serine/threonine kinase involved in the regulation of G protein-coupled receptor (GPCR) signaling pathways. As a critical modulator of receptor desensitization, internalization, and resensitization, GRK2 plays a pivotal role in controlling the intensity and duration of cellular responses to a wide range of extracellular signals. The ability to selectively target GRK2 with a dedicated inhibitor like GRK2i provides researchers with a powerful tool to dissect the molecular mechanisms governing GPCR-mediated signal transduction and to explore the broader implications of kinase regulation in cellular physiology.
Signal Transduction Research: GRK2i is widely utilized in fundamental studies aimed at elucidating the molecular mechanisms of GPCR signaling. By selectively inhibiting GRK2 activity, researchers can assess the specific contributions of this kinase to receptor phosphorylation events, arrestin recruitment, and subsequent receptor internalization. These investigations are essential for understanding the dynamic regulation of GPCR responsiveness and for mapping the intricate networks that govern receptor-mediated cellular communication.
Kinase Selectivity Profiling: The compound is frequently employed in kinase profiling assays to evaluate the specificity and selectivity of GRK2 inhibition relative to other members of the GRK family or related protein kinases. Such studies are critical for validating the compound's utility as a research tool and for identifying potential off-target effects, thereby informing the development of next-generation kinase inhibitors with improved selectivity profiles.
Cellular Signaling Pathway Analysis: In cell-based models, GRK2i enables detailed examination of downstream signaling events following GPCR activation. By modulating GRK2-dependent phosphorylation and desensitization processes, investigators can dissect the temporal and spatial dynamics of second messenger production, such as cyclic AMP or intracellular calcium flux, and delineate the impact of altered kinase activity on broader cellular responses. These insights are invaluable for constructing accurate models of signal integration and cross-talk within complex cellular environments.
Receptor Trafficking Studies: The inhibitor is instrumental in research focused on receptor trafficking, particularly in studies investigating the mechanisms of GPCR internalization, recycling, and degradation. By blocking GRK2-mediated phosphorylation, GRK2i allows for the assessment of how altered kinase activity affects receptor fate, localization, and the restoration of signaling competence. These applications contribute to a deeper understanding of receptor lifecycle regulation and the maintenance of cellular homeostasis.
Pharmacological Screening: GRK2i serves as a reference compound in high-throughput screening assays designed to identify new modulators of GRK2 or to evaluate the pharmacological properties of novel inhibitors. Its use in these platforms provides a benchmark for comparative analysis, facilitating the discovery and characterization of compounds with potential utility in basic research or drug development. Through these applications, the inhibitor supports the advancement of kinase-targeted research and the exploration of novel regulatory mechanisms within the GPCR signaling landscape.
1. Cationic cell-penetrating peptides are potent furin inhibitors
2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
3. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More